FR2267116B1 - - Google Patents

Info

Publication number
FR2267116B1
FR2267116B1 FR7511535A FR7511535A FR2267116B1 FR 2267116 B1 FR2267116 B1 FR 2267116B1 FR 7511535 A FR7511535 A FR 7511535A FR 7511535 A FR7511535 A FR 7511535A FR 2267116 B1 FR2267116 B1 FR 2267116B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7511535A
Other languages
French (fr)
Other versions
FR2267116A1 (tr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2418218A external-priority patent/DE2418218A1/de
Priority claimed from DE19742459515 external-priority patent/DE2459515C3/de
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2267116A1 publication Critical patent/FR2267116A1/fr
Application granted granted Critical
Publication of FR2267116B1 publication Critical patent/FR2267116B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7511535A 1974-04-13 1975-04-14 Expired FR2267116B1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2418218A DE2418218A1 (de) 1974-04-13 1974-04-13 Neue arzneimittel-zubereitung mit antidiabetischer wirkung
DE19742459515 DE2459515C3 (de) 1974-12-17 1974-12-17 Arzneimittelzubereitungen mit antidiabetischer Wirkung

Publications (2)

Publication Number Publication Date
FR2267116A1 FR2267116A1 (tr) 1975-11-07
FR2267116B1 true FR2267116B1 (tr) 1978-10-06

Family

ID=25766977

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7511535A Expired FR2267116B1 (tr) 1974-04-13 1975-04-14

Country Status (11)

Country Link
AU (1) AU500430B2 (tr)
CA (1) CA1047919A (tr)
EG (1) EG12098A (tr)
ES (1) ES436398A1 (tr)
FI (1) FI751084A (tr)
FR (1) FR2267116B1 (tr)
GB (1) GB1492837A (tr)
IE (1) IE40985B1 (tr)
IL (1) IL47043A (tr)
LU (1) LU72269A1 (tr)
NL (1) NL7504165A (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560232A (en) * 1977-02-01 1980-01-30 Novo Industri As Biphasic insulin preparations comprising crystalline insulin and monodesamido insulin
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
CA2225963C (en) 1995-07-25 2008-02-05 Novartis Ag Transforming growth factor beta crystals

Also Published As

Publication number Publication date
ES436398A1 (es) 1977-05-01
NL7504165A (nl) 1975-10-15
IL47043A0 (en) 1975-06-25
AU8007375A (en) 1976-10-14
IE40985B1 (en) 1979-09-26
LU72269A1 (tr) 1977-02-03
EG12098A (en) 1980-12-31
FI751084A (tr) 1975-10-14
CA1047919A (en) 1979-02-06
IL47043A (en) 1978-06-15
IE40985L (en) 1975-10-13
FR2267116A1 (tr) 1975-11-07
AU500430B2 (en) 1979-05-24
GB1492837A (en) 1977-11-23

Similar Documents

Publication Publication Date Title
FR2260072B1 (tr)
FR2260378A1 (tr)
FR2284233B3 (tr)
FI750824A (tr)
FR2285381B1 (tr)
FR2267116B1 (tr)
FR2275465B1 (tr)
AU495920B2 (tr)
FR2258147B1 (tr)
IN138546B (tr)
AU7138274A (tr)
AU7099174A (tr)
CH1357474A4 (tr)
BG22309A1 (tr)
BG19607A1 (tr)
AU481082A (tr)
AU482110A (tr)
DD119250A5 (tr)
DD110367A1 (tr)
AU482019A (tr)
DD109825A1 (tr)
BG19982A1 (tr)
CH1107074A4 (tr)
BG26152A1 (tr)
BG23188A1 (tr)

Legal Events

Date Code Title Description
ST Notification of lapse